GlassScriptPhysician profile
Roua Kahila
NPI 1184284846
$2,685.98
in general payments reported to CMS, 2019-2025
18 companies · $16.10 in 2025
The $16.10 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $514 · 2022: $930 · 2023: $670 · 2024: $557 · 2025: $16.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $450.94 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $321.59 | 2021-2024 | Zeposia |
| Genzyme Corporation | $313.37 | 2022-2024 | |
| Abbvie INC. | $301.71 | 2022-2023 | |
| Catalyst Pharmaceuticals, INC. | $233.80 | 2021-2024 | |
| Biogen, INC. | $214.78 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $135.46 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $125.00 | 2021 | |
| Eisai INC. | $124.93 | 2024 | |
| Horizon Therapeutics Plc | $102.32 | 2022-2023 | Uplizna |
| Neurelis, INC. | $100.69 | 2023 | Valtoco |
| Grifols USA, LLC | $62.48 | 2023 | Gamunex-C |
| Banner Life Sciences, LLC | $57.42 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $42.60 | 2023 | Aptiom |
| Mdd US Operations, LLC | $36.99 | 2023-2025 | Gocovri, Gocovri |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $29.33 | 2022 | |
| Pfizer INC. | $18.54 | 2023 | |
| Sandoz INC. | $14.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roua Kahila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.